Early intraneuronal amyloid triggers neuron-derived inflammatory signaling in APP transgenic rats and human brain. 2020

Lindsay A Welikovitch, and Sonia Do Carmo, and Zsófia Maglóczky, and Janice C Malcolm, and János Lőke, and William L Klein, and Tamás Freund, and A Claudio Cuello
Department of Neurology and Neurosurgery, McGill University, Montreal, QC H3G 1Y6, Canada.

Chronic inflammation during Alzheimer's disease (AD) is most often attributed to sustained microglial activation in response to amyloid-β (Aβ) plaque deposits and cell death. However, cytokine release and microgliosis are consistently observed in AD transgenic animal models devoid of such pathologies, bringing into question the underlying processes that may be at play during the earliest AD-related immune response. We propose that this plaque-independent inflammatory reaction originates from neurons burdened with increasing levels of soluble and oligomeric Aβ, which are known to be the most toxic amyloid species within the brain. Laser microdissected neurons extracted from preplaque amyloid precursor protein (APP) transgenic rats were found to produce a variety of potent immune factors, both at the transcript and protein levels. Neuron-derived cytokines correlated with the extent of microglial activation and mobilization, even in the absence of extracellular plaques and cell death. Importantly, we identified an inflammatory profile unique to Aβ-burdened neurons, since neighboring glial cells did not express similar molecules. Moreover, we demonstrate within disease-vulnerable regions of the human brain that a neuron-specific inflammatory response may precede insoluble Aβ plaque and tau tangle formation. Thus, we reveal the Aβ-burdened neuron as a primary proinflammatory agent, implicating the intraneuronal accumulation of Aβ as a significant immunological component in the AD pathogenesis.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008297 Male Males
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D000686 Amyloidosis A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits. Amyloidoses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Lindsay A Welikovitch, and Sonia Do Carmo, and Zsófia Maglóczky, and Janice C Malcolm, and János Lőke, and William L Klein, and Tamás Freund, and A Claudio Cuello
January 2003, Neuroreport,
Lindsay A Welikovitch, and Sonia Do Carmo, and Zsófia Maglóczky, and Janice C Malcolm, and János Lőke, and William L Klein, and Tamás Freund, and A Claudio Cuello
June 2022, Viruses,
Lindsay A Welikovitch, and Sonia Do Carmo, and Zsófia Maglóczky, and Janice C Malcolm, and János Lőke, and William L Klein, and Tamás Freund, and A Claudio Cuello
February 2008, Genes, brain, and behavior,
Lindsay A Welikovitch, and Sonia Do Carmo, and Zsófia Maglóczky, and Janice C Malcolm, and János Lőke, and William L Klein, and Tamás Freund, and A Claudio Cuello
July 2002, Brain pathology (Zurich, Switzerland),
Lindsay A Welikovitch, and Sonia Do Carmo, and Zsófia Maglóczky, and Janice C Malcolm, and János Lőke, and William L Klein, and Tamás Freund, and A Claudio Cuello
October 1998, Nature,
Lindsay A Welikovitch, and Sonia Do Carmo, and Zsófia Maglóczky, and Janice C Malcolm, and János Lőke, and William L Klein, and Tamás Freund, and A Claudio Cuello
October 2002, Journal of neurobiology,
Lindsay A Welikovitch, and Sonia Do Carmo, and Zsófia Maglóczky, and Janice C Malcolm, and János Lőke, and William L Klein, and Tamás Freund, and A Claudio Cuello
September 2009, FEBS letters,
Lindsay A Welikovitch, and Sonia Do Carmo, and Zsófia Maglóczky, and Janice C Malcolm, and János Lőke, and William L Klein, and Tamás Freund, and A Claudio Cuello
February 2008, Neurobiology of aging,
Lindsay A Welikovitch, and Sonia Do Carmo, and Zsófia Maglóczky, and Janice C Malcolm, and János Lőke, and William L Klein, and Tamás Freund, and A Claudio Cuello
October 2006, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Lindsay A Welikovitch, and Sonia Do Carmo, and Zsófia Maglóczky, and Janice C Malcolm, and János Lőke, and William L Klein, and Tamás Freund, and A Claudio Cuello
January 2019, Current molecular medicine,
Copied contents to your clipboard!